Prometheus Biosciences, Inc. Quarterly Return On Equity in % from Q4 2020 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Prometheus Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q1 2023.
  • Prometheus Biosciences, Inc. Return On Equity for the quarter ending March 31, 2023 was -33.5 %, a 23.7% increase year-over-year.
  • Prometheus Biosciences, Inc. annual Return On Equity for 2022 was -43.4 %, a 29.8% decline from 2021.
  • Prometheus Biosciences, Inc. annual Return On Equity for 2021 was -33.4 %, a 161% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -33.5 +10.4 +23.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -43.4 -9.97 -29.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -61.4 -24.5 -66.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -54.9 -8.74 -18.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -43.9 +147 +76.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -33.4 -88.3 -161% Oct 1, 2021 Dec 31, 2021
Q3 2021 -36.9 Jul 1, 2021 Sep 30, 2021
Q2 2021 -46.2 Apr 1, 2021 Jun 30, 2021
Q1 2021 -190 Jan 1, 2021 Mar 31, 2021
Q4 2020 54.9 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.